Objectives-The relationship between elevated inflammatory cytokine levels and peak pain intensity following acute musculoskeletal injury has not been fully elucidated in high risk subgroups. Identifying the role that these cytokines have on pain responses may help with developing tailored therapeutic approaches.Methods-Data were collected from 54 participants who were vulnerable to a robust pain response and delayed recovery following musculoskeletal injury. Participants completed baseline active and resting pain measurements (Brief Pain Inventory) and a blood draw prior to an exercised induced shoulder muscle injury. Participants returned at 24 hours and 48 hours post-injury for follow-up pain measurements and blood draws. Blood plasma was analyzed for IL-1β, IL-6, IL-8, IL-10 and TNFα. Pearson bivariate correlations were performed between cytokines and pain measurements to identify candidate variables for stepwise multiple linear regression predicting pain intensity reports.Results-Pearson bivariate correlation identified 13/45 correlations between inflammatory cytokines and resting pain intensity and 9/45 between inflammatory cytokines and active pain (p<0.05, r≥0.3 or r≤−0.3). This led to 5 stepwise multiple linear regression models, of which 4 met the statistical criterion (p<0.0167); including IL-10 baseline plasma concentrations predicting active pain (r 2 =0.19) and resting pain (r 2 =0.15) intensity 48 hours post-injury. IL-6 and IL-10 plasma concentrations at 48 hours were respectively associated with active and resting pain at 48 hours.
Positive expectations before a sham treatment enhanced reduction in pain intensity but did not improve functional impairments following exercise-induced acute musculoskeletal injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.